A practical reference on NAD+ assay: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Quantification of NAD+ in biological samples usually relies on separation techniques coupled to sensitive detection. High-performance liquid chromatography with ultraviolet detection can measure the oxidized form by its absorbance near 260 nm, while mass spectrometry provides greater specificity and can distinguish NAD+ from close analogs. Enzymatic cycling assays use coupled dehydrogenase reactions to amplify signal and estimate NAD+ concentrations in cell or tissue extracts. Because NAD+ and NADH interconvert rapidly, sample preparation must quench metabolism quickly and preserve the redox state before analysis.
The stability of NAD+ depends on pH, temperature, light exposure, and the presence of degradative enzymes. Aqueous solutions are generally more stable under mildly acidic to neutral conditions and degrade faster under alkaline conditions or prolonged heat. The solid is hygroscopic and should be stored desiccated, often frozen, and protected from repeated freeze-thaw cycles. In laboratory handling, aliquots reduce repeated temperature changes, and chelating agents may limit metal-catalyzed hydrolysis in some buffers. These practices matter because even small amounts of NADH or hydrolysis products can interfere with quantitative assays.
Quality control for NAD+ materials typically combines identity, purity, and water content checks. Identity may be confirmed by ultraviolet spectrum, retention time in chromatography, or mass accuracy, while purity is assessed by HPLC peak area or quantitative nuclear magnetic resonance. Residual water and solvents can affect molar calculations and enzyme assays, so Karl Fischer titration or thermogravimetric analysis may be used. Commercial materials vary in grade and counterion form, and published methods should specify the exact salt or hydrate when reporting concentrations. Regulatory status depends on intended use, with research reagents, dietary ingredients, and clinical products treated under different frameworks.
Laboratory measurement of NAD+ usually begins with rapid sample quenching because the molecule can change form after collection. Enzymatic cycling assays amplify signal through coupled reactions and are suited to small samples. High-performance liquid chromatography with ultraviolet detection separates NAD+ from related nucleotides. Liquid chromatography-mass spectrometry offers higher specificity and can distinguish NAD+ from close analogs. Each method has trade-offs in sensitivity, throughput, and equipment needs, so reported values depend heavily on extraction and detection choices.
Stability of NAD+ depends on form, temperature, pH, and water content. The solid is generally more stable than solutions, and it should be kept dry and cold. In solution, hydrolysis can cleave the dinucleotide, especially under alkaline conditions or at elevated temperature. Light exposure may also contribute to degradation. Buffers, chelating agents, and sterile handling can reduce losses, but no single condition preserves all preparations indefinitely. Researchers often prepare working solutions shortly before use and verify activity or purity after storage.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated; avoid repeated freeze-thaw cycles. |
| Typical analytical method | LC-MS or HPLC with UV detection | Absorbance at 260 nm used for concentration estimates. |
| Reduced form absorbance | 340 nm | NADH absorbs at 340 nm; NAD+ does not. |
| Aqueous stability | pH-dependent | Degradation increases with alkaline pH and heat. |
| Purity check | HPLC purity and UV spectrum | Identity confirmed by retention time and absorbance ratio. |
Purified NAD+ is typically supplied as a white to off-white powder and stored desiccated at low temperature. Airtight containers limit moisture uptake, while protection from light reduces degradation of the nicotinamide ring. Aqueous stock solutions are less stable than solid material and are often aliquoted before freezing. Repeated freeze-thaw cycles can lower integrity, so working portions are kept separate. Purity is commonly checked by ultraviolet absorbance near 260 nm, high-performance liquid chromatography, or mass spectrometry.
Stability studies show that NAD+ can hydrolyze under prolonged heat, extreme pH, or microbial contamination. Phosphate buffers near neutral pH are often used for short-term handling, though exact stability depends on concentration, temperature, and matrix. In biological samples, endogenous enzymes can rapidly degrade NAD+, making cold chain and fast processing important. Analytical reports should state extraction conditions, internal standards, and validation parameters. Without those details, comparisons across studies remain difficult and potentially misleading.
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a dinucleotide composed of two nucleotides joined by phosphate groups. One nucleotide contains adenine; the other contains nicotinamide. The molecule exists in oxidized (NAD+) and reduced (NADH) forms, and the reversible hydride transfer between them underlies many metabolic oxidation-reduction reactions. In cells, NAD+ serves as an electron acceptor in pathways such as glycolysis, the citric acid cycle, and oxidative phosphorylation. Its concentration and redox ratio vary by compartment, tissue, and metabolic state.
Beyond redox chemistry, NAD+ is consumed as a substrate by enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins use NAD+ in deacylation reactions, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 hydrolases convert it to signaling metabolites. Because these enzymes compete for the same pool, changes in NAD+ availability can influence multiple cellular processes. The relative contribution of each consumption route differs by cell type and condition, and precise quantitative links remain an active area of study.
Research on NAD+ spans biochemistry, aging biology, and metabolism. Studies often examine how NAD+ levels change with age, diet, exercise, or disease states, and whether precursor supplementation alters those levels. Findings in animal models do not automatically translate to humans, and measurement methods vary across studies. Questions about tissue-specific effects, long-term consequences, and causal relationships remain open. NAD+ itself is not established as a single therapeutic agent with a broad clinical role.
NAD+ is a dinucleotide composed of two nucleotides joined by a pyrophosphate linkage. One nucleotide contains adenine, and the other contains nicotinamide. The oxidized form carries a positive charge on the nicotinamide ring and is abbreviated NAD+. It functions as a cofactor in hydride-transfer reactions, accepting electrons in catabolic pathways. In cells, it interconverts with reduced NADH, forming a redox couple central to energy metabolism. The molecule is water-soluble and does not cross cell membranes freely without specific transport or precursor pathways.
The nicotinamide ring undergoes reversible reduction at the para position, converting NAD+ to NADH. This reaction transfers a hydride equivalent, not a free hydrogen atom or electron alone. Because the redox pair has a defined reduction potential, it links oxidation of fuels to respiratory chain activity. Many dehydrogenases use NAD+ as a co-substrate and produce NADH. The ratio of NAD+ to NADH reflects metabolic state and influences flux through several pathways.
NAD+ also serves as a substrate for enzymes that cleave it, including sirtuins, PARPs, and CD38. These enzymes consume NAD+ and release nicotinamide and ADP-ribose or related products. The dual roles as redox cofactor and signaling substrate connect NAD+ to DNA repair, circadian regulation, and calcium signaling. Cellular NAD+ concentrations vary by tissue, time of day, and stress exposure. How these consumption pathways interact with redox balance remains an active area of research.
Taurine ( ; IUPAC: 2-aminoethanesulfonic acid) is a naturally occurring organic compound with the chemical formula H2N−CH2−CH2−SO2−OH in its non-zwitterionic form and H3N+−CH2−CH2−SO−3 in its zwitterionic form, and is a non-proteinogenic amino sulfonic acid widely distributed in mammalian tissues and organs. Structurally, by containing a sulfonic acid group instead of a carboxylic acid group, it is not involved in protein synthesis but is still usually referred to as an amino acid; however, being non-proteinogenic, it is not a component of the genetic code and is distinguished from the protein-building α-amino acids. Taurine is a major constituent of bile and can be found in the large intestine. It is named after Latin taurus, meaning bull or ox, as it was first isolated from ox bile in 1827 by German scientists Friedrich Tiedemann and Leopold Gmelin. Although taurine is abundant in human organs, it is not an essential human dietary nutrient and is not included among nutrients with a recommended intake level. Among the diverse pathways by which natural taurine can be biosynthesized, its human pathways (primarily in the human liver) are from cysteine and/or methionine. Taurine is commonly sold as a dietary supplement. Taurine is used as a food additive to meet essential dietary intake levels for cats, and supplemental dietary support for dogs and poultry.
is the second viscosity coefficient (or bulk viscosity). If a fluid does not obey this relation, it is termed a non-Newtonian fluid, of which there are several types. Non-Newtonian fluids can be either plastic, Bingham plastic, pseudoplastic, dilatant, thixotropic, rheopectic, viscoelastic. In some applications, another rough broad division among fluids is made: ideal and non-ideal fluids. An ideal fluid is non-viscous and offers no resistance whatsoever to a shearing force. An ideal fluid really does not exist, but in some calculations, the assumption is justifiable. One example of this is the flow far from solid surfaces. In many cases, the viscous effects are concentrated near the solid boundaries (such as in boundary layers) while in regions of the flow field far away from the boundaries the viscous effects can be neglected and the fluid there is treated as it were inviscid (ideal flow). When the viscosity is neglected, the term containing the viscous stress tensor
Thymosin beta-4 is considered a performance-enhancing substance and is banned in sports by the World Anti-Doping Agency due to its effect of aiding soft tissue recovery and enabling higher training loads. It was central to two controversies in Australia in the 2010s which saw a large proportion of the playing lists from two professional football clubs – the Cronulla-Sutherland Sharks of the National Rugby League and the Essendon Football Club of the Australian Football League – found guilty of doping and suspended from playing; in both cases, the players were administered thymosin beta-4 in a program organised by sports scientist Stephen Dank.
Sources: en.wikipedia.org
=== Life expectancy === The maximum lifespan of bats is three-and-a-half times that of other mammals of similar size; a Siberian bat (Myotis sibiricus) was recaptured in the wild after 41 years, making it the oldest known bat. One hypothesis consistent with the rate-of-living theory links this to the fact that they slow their metabolic rate while hibernating: bats that hibernate, on average, have a longer lifespan than bats that do not. Another hypothesis states that lower mortality is linked to flying, which would also be true for birds and gliding mammals. In addition, female bats that give birth to multiple pups annually generally have reduced lifespans compared to those that have one pup. Also, cave-roosting species may have a longer lifespan than non-roosting species due to less predation in caves.
There has been uncertainty about which biological target interactions mediate the psychoactive and other effects of ibogaine. Rodent drug discrimination studies with ibogaine have been employed to help elucidate these interactions. Ibogaine partially substitutes for the serotonergic psychedelics LSD and DOM and this can be blocked by the serotonin 5-HT2 receptor antagonist pizotifen. Similarly, LSD and DOM partially substitute for ibogaine and this can be blocked by the serotonin 5-HT2A receptor antagonist pirenperone. The serotonin releasing agent and potent serotonin 5-HT2 receptor agonist fenfluramine also partially substitutes for ibogaine. The preferential serotonin 5-HT2C receptor agonists MK-212 and mCPP partially substitute for ibogaine as well and this can be blocked by the serotonin 5-HT2 receptor antagonist metergoline. The preceding findings suggest that serotonin 5-HT2A and 5-HT2C receptor activation are involved in the subjective effects of ibogaine. Conversely, the serotonin 5-HT1A and 5-HT3 receptors do not appear to be involved. Although serotonin 5-HT2A receptor signaling appears to be involved in the effects of ibogaine, neither ibogaine nor its major active metabolite noribogaine appears to act as a direct serotonin 5-HT2A receptor agonist. In addition, in contrast to the findings in drug discrimination studies, ibogaine fails to produce the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.
==== Charitable contributions tax deduction ==== As of 2026, corporations may take a tax deduction for charitable contributions for the amount that exceeds 1 percent of its taxable income and does not exceed 10 percent of its taxable income. Charitable contributions that do not qualify for a tax deduction because of this change may be carried forward for five years.
The canal remained a remote and sparsely populated wilderness, unchanged over centuries. The Upper Orinoco, at its junction with the Casiquiare, was over a thousand miles from the sea and still more than a quarter mile wide. The expedition proceeded to Esmeralda, a remote mission at the foot of the Sierra Duida. The settlement was isolated and regarded as a place of hardship, plagued by insects and food shortages. Esmeralda was famous for the production of curare, a potent poison prepared by local Natives. Humboldt and Bonpland observed its preparation and collected samples, narrowly avoiding accidental poisoning. Hostile indigenous groups upriver from Esmeralda forced the party to abandon plans to explore the Orinoco’s source. Weakened by insects, poor food, and cramped conditions, the expedition left Esmeralda on 23 May. They traveled rapidly downstream, reaching the Atures rapids by the end of May. Humboldt visited the cavern of Ataruipe, discovering hundreds of well-preserved Native skeletons. He collected several for scientific study, which later caused difficulties with locals who recognized the resin used in their preparation. The expedition passed through the rapids for the last time. Father Zea left to rejoin his mission. Many of the local Natives suffered from illness. Bonpland soon fell sick but continued to collect plants despite worsening health. In early June, the group reached Uruana and encountered the Ottomac people. Humboldt described them as unruly, hard to govern, and addicted to a hallucinogenic drug.
Sources: en.wikipedia.org
== Habitat and ecology == Aspergillus parasiticus can be found outdoors commonly within an agricultural setting of soil on fields and through the improper handling, drying, transportation and storage of grains and fresh produce. This fungus is also commonly found on the stems and roots of peanuts and other plants. A. parasiticus is a tropical and subtropical species found in the United States, Latin America, South Africa, India and Australia. This species has rarely been reported from Southeast Asia and cool temperate zones. Fungal spores can be distributed with the wind as well as through moist soil via contact with nuts and kernels, and can survive over the winter months on plant material on the soil.
Protein digestibility-corrected amino acid score (PDCAAS) is a method of evaluating the quality of a protein based on both the amino acid requirements of humans and their ability to digest it. The PDCAAS rating was recommended by the Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO) in 1989 (report published in 1991). It was adopted by the US FDA in 1993 as "the preferred 'best'" method to determine protein quality. In 2013, FAO proposed changing to Digestible Indispensable Amino Acid Score.
=== Healthcare reform === The CBO has consistently reported since 2010 that the Patient Protection and Affordable Care Act (also known as "Obamacare") would reduce the deficit, as its tax increases and reductions in future Medicare spending offset its incremental spending for subsidies for low-income households. The CBO reported in June 2015 that repeal of the ACA would increase the deficit between $137 billion and $353 billion over the 2016–2025 period in total, depending on the impact of macroeconomic feedback effects. In other words, ACA is a deficit reducer, as its repeal would raise the deficit. The Medicare Trustees provide an annual report of the program's finances. The forecasts from 2009 and 2015 differ materially, mainly due to changes in the projected rate of healthcare cost increases, which have moderated considerably. Rather than rising to nearly 12% GDP over the forecast period (through 2080) as forecast in 2009, the 2015 forecast has Medicare costs rising to 6% GDP, comparable to the Social Security program. The increase in healthcare costs is one of the primary drivers of long-term budget deficits. The long-term budget situation has considerably improved in the 2015 forecast versus the 2009 forecast per the Trustees Report. U.S. healthcare costs were approximately $3.2 trillion or nearly $10,000 per person on average in 2015, the equivalent of roughly $14,000 per person in 2025. Major categories of expense include hospital care (32%), physician and clinical services (20%), and prescription drugs (10%). U.S.
Sources: en.wikipedia.org
Common methods include LC-MS, HPLC with UV detection, and enzymatic cycling assays. Rapid quenching is needed because NAD+ and NADH interconvert. The chosen method should be validated for the sample matrix.
Solid NAD+ is typically stored desiccated at -20 °C or lower. Aqueous solutions are less stable and should be prepared fresh or frozen in aliquots. Repeated freeze-thaw cycles can reduce integrity.
NADH, NAD+ analogs, hydrolysis products, and residual solvents can interfere. Buffer pH and metal ions may also affect stability or enzyme activity. Blank controls and calibration curves help identify such problems.
Common methods include enzymatic cycling assays, HPLC with UV detection, and LC-MS. The choice depends on sample size, specificity needs, and available equipment. Rapid quenching before analysis is important because NAD+ and NADH can interconvert.